248 related articles for article (PubMed ID: 34409724)
1. Synthesis, Characterization, and Biological Study of 3-Trifluoromethylpyrazole Tethered Chalcone-Pyrrole and Pyrazoline-Pyrrole Derivatives.
Kisan Rasal N; Bhaskar Sonawane R; Vijay Jagtap S
Chem Biodivers; 2021 Oct; 18(10):e2100504. PubMed ID: 34409724
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, biological evaluation, and in silico study of pyrazoline-conjugated 2,4-dimethyl-1H-pyrrole-3-carboxylic acid derivatives.
Rasal NK; Sonawane RB; Jagtap SV
Arch Pharm (Weinheim); 2021 Feb; 354(2):e2000267. PubMed ID: 33078449
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents.
Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA
Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of novel pyrazolic analogues of chalcones and their 3-aryl-4-(3-aryl-4,5-dihydro-1H-pyrazol-5-yl)-1-phenyl-1H-pyrazole derivatives as potential antitumor agents.
Insuasty B; Tigreros A; Orozco F; Quiroga J; Abonía R; Nogueras M; Sanchez A; Cobo J
Bioorg Med Chem; 2010 Jul; 18(14):4965-74. PubMed ID: 20594863
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of some new pyrazoline substituted benzenesulfonylureas as potential antiproliferative agents.
Rathore P; Yaseen S; Ovais S; Bashir R; Yaseen R; Hameed AD; Samim M; Gupta R; Hussain F; Javed K
Bioorg Med Chem Lett; 2014 Apr; 24(7):1685-91. PubMed ID: 24630557
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, topoisomerase I & II inhibitory activity, antiproliferative activity, and structure-activity relationship study of pyrazoline derivatives: An ATP-competitive human topoisomerase IIα catalytic inhibitor.
Ahmad P; Woo H; Jun KY; Kadi AA; Abdel-Aziz HA; Kwon Y; Rahman AF
Bioorg Med Chem; 2016 Apr; 24(8):1898-908. PubMed ID: 26988802
[TBL] [Abstract][Full Text] [Related]
7. Molecular Docking and In Vitro Anticancer Screening of Synthesized Arylthiazole linked 2H-indol-2-one Derivatives as VEGFR-2 Kinase Inhibitors.
Shalmali N; Bawa S; Ali MR; Kalra S; Kumar R; Zeya B; Rizvi MA; Partap S; Husain A
Anticancer Agents Med Chem; 2022; 22(11):2166-2180. PubMed ID: 34792005
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of some dihydropyrimidine-based compounds bearing pyrazoline moiety and evaluation of their antiproliferative activity.
Awadallah FM; Piazza GA; Gary BD; Keeton AB; Canzoneri JC
Eur J Med Chem; 2013; 70():273-9. PubMed ID: 24161704
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, biological evaluation, and molecular docking studies of N-((1,3-diphenyl-1H-pyrazol-4-yl)methyl)aniline derivatives as novel anticancer agents.
Huang XF; Lu X; Zhang Y; Song GQ; He QL; Li QS; Yang XH; Wei Y; Zhu HL
Bioorg Med Chem; 2012 Aug; 20(16):4895-900. PubMed ID: 22819191
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of 1-substituted 3-aryl-5-aryl(hetaryl)-2-pyrazolines and study of their antitumor activity.
Insuasty B; Chamizo L; Muñoz J; Tigreros A; Quiroga J; Abonía R; Nogueras M; Cobo J
Arch Pharm (Weinheim); 2012 Apr; 345(4):275-86. PubMed ID: 22105771
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and in vitro screening of phenylbipyridinylpyrazole derivatives as potential antiproliferative agents.
Al-Sanea MM; Elkamhawy A; Zakaria A; Park BS; Kwon Y; Lee SH; Lee SW; Kim IT
Molecules; 2015 Jan; 20(1):1031-45. PubMed ID: 25584833
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of novel quinoline-based 4,5-dihydro-1H-pyrazoles as potential anticancer, antifungal, antibacterial and antiprotozoal agents.
Ramírez-Prada J; Robledo SM; Vélez ID; Crespo MDP; Quiroga J; Abonia R; Montoya A; Svetaz L; Zacchino S; Insuasty B
Eur J Med Chem; 2017 May; 131():237-254. PubMed ID: 28329730
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, cytotoxicity, HuTopoIIα inhibitory activity and molecular docking studies of pyrazole derivatives as potential anticancer agents.
Alam R; Wahi D; Singh R; Sinha D; Tandon V; Grover A; Rahisuddin
Bioorg Chem; 2016 Dec; 69():77-90. PubMed ID: 27744115
[TBL] [Abstract][Full Text] [Related]
14. Indole-Acrylonitrile Derivatives as Potential Antitumor and Antimicrobial Agents-Synthesis, In Vitro and In Silico Studies.
Kornicka A; Gzella K; Garbacz K; Jarosiewicz M; Gdaniec M; Fedorowicz J; Balewski Ł; Kokoszka J; Ordyszewska A
Pharmaceuticals (Basel); 2023 Jun; 16(7):. PubMed ID: 37513830
[TBL] [Abstract][Full Text] [Related]
15. Novel Pyrazolo[3,4-d]pyrimidines as Potential Cytotoxic Agents: Design, Synthesis, Molecular Docking and CDK2 Inhibition.
Maher M; Kassab AE; Zaher AF; Mahmoud Z
Anticancer Agents Med Chem; 2019; 19(11):1368-1381. PubMed ID: 31038080
[TBL] [Abstract][Full Text] [Related]
16. New chalcone-type compounds and 2-pyrazoline derivatives: synthesis and caspase-dependent anticancer activity.
Chouiter MI; Boulebd H; Pereira DM; Valentão P; Andrade PB; Belfaitah A; Silva AM
Future Med Chem; 2020 Mar; 12(6):493-509. PubMed ID: 32100558
[No Abstract] [Full Text] [Related]
17. Potential 2,4-dimethyl-1H-pyrrole-3-carboxamide bearing benzimidazole template: Design, synthesis, in vitro anticancer and in silico ADME study.
Rasal NK; Sonawane RB; Jagtap SV
Bioorg Chem; 2020 Apr; 97():103660. PubMed ID: 32086056
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of chalcones and their derived pyrazoles as potential cytotoxic agents.
Bhat BA; Dhar KL; Puri SC; Saxena AK; Shanmugavel M; Qazi GN
Bioorg Med Chem Lett; 2005 Jun; 15(12):3177-80. PubMed ID: 15893928
[TBL] [Abstract][Full Text] [Related]
19. Novel piperazine-chalcone hybrids and related pyrazoline analogues targeting VEGFR-2 kinase; design, synthesis, molecular docking studies, and anticancer evaluation.
Ahmed MF; Santali EY; El-Haggar R
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):307-318. PubMed ID: 33349069
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological evaluation of a new series of thiazolyl-pyrazolines as dual EGFR and HER2 inhibitors.
Sever B; Altıntop MD; Radwan MO; Özdemir A; Otsuka M; Fujita M; Ciftci HI
Eur J Med Chem; 2019 Nov; 182():111648. PubMed ID: 31493743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
